Tumor-infiltrating lymphocytes in early breast cancer: an exploratory analysis focused on HER2+ subtype in Portuguese patients.

MLA

Luz, Paulo, et al. “Tumor-Infiltrating Lymphocytes in Early Breast Cancer: An Exploratory Analysis Focused on HER2+ Subtype in Portuguese Patients.” Current Medical Research and Opinion, vol. 38, no. 8, Aug. 2022, pp. 1379–82. EBSCOhost, https://doi.org/10.1080/03007995.2022.2096334.

APA

Luz, P., Fernandes, I., Magalhães, J., Sousa, R. T. de, Faísca, P., Costa, J. G., & Fernandes, A. S. (2022). Tumor-infiltrating lymphocytes in early breast cancer: an exploratory analysis focused on HER2+ subtype in Portuguese patients. Current Medical Research and Opinion, 38(8), 1379–1382. https://doi.org/10.1080/03007995.2022.2096334

Chicago

Luz, Paulo, Isabel Fernandes, Joana Magalhães, Rita Teixeira de Sousa, Pedro Faísca, João G Costa, and Ana S Fernandes. 2022. “Tumor-Infiltrating Lymphocytes in Early Breast Cancer: An Exploratory Analysis Focused on HER2+ Subtype in Portuguese Patients.” Current Medical Research and Opinion 38 (8): 1379–82. doi:10.1080/03007995.2022.2096334.